RTS,S is the first malaria vaccine to reach advanced trials . 
  Drug firm GlaxoSmithKline has applied for a licence from the European Medicines Agency . 
  Tests were carried out on 15,500 toddlers and babies in sub-Saharan Africa . 
  Vaccine could be approved by October and could save millions of lives . 
 